Lehrer-Graiwer Joshua

CIK 00017896732 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001789673

Recent Transactions

50 trades

Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2023-02-21+600,000→ 600,000 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2022-02-16+650,000→ 650,000 total
Conversion
LENZ Therapeutics, Inc.$LENZ
Series B Preferred Stock
2021-06-29−19,763→ 0 total
Conversion
LENZ Therapeutics, Inc.$LENZ
Common Stock
2021-06-29+8,126→ 1,161,670 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2021-03-17+340,798→ 340,798 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2021-03-17+795,196→ 795,196 total
Award
LENZ Therapeutics, Inc.$LENZ
Series B Preferred Stock
2021-03-11$5.06/sh+19,763→ 19,763 total
Exercise/Conversion
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2021-01-16−374,013→ 0 total
Exercise/Conversion
LENZ Therapeutics, Inc.$LENZ
Common Stock
2021-01-16$0.30/sh+374,013→ 1,153,544 total
Award
LENZ Therapeutics, Inc.$LENZ
Stock Option (right to buy)
2021-01-13+374,013→ 374,013 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-03-09$59.90/sh−938→ 2,595 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-03-09−938→ 1,875 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-03-09$19.89/sh+938→ 3,533 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-03-05$65.30/sh−1,138→ 2,595 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-03-01+1,750→ 4,345 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-03-01−1,750→ 3,500 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-03-01$63.96/sh−612→ 3,733 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-02-18$26.90/sh+1,313→ 3,908 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-02-18$69.71/sh−1,313→ 2,595 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-18−1,313→ 5,250 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-10−625→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-02-10$12.95/sh+625→ 3,220 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-02-10$70.48/sh−625→ 2,595 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-02-06$72.40/sh−3,937→ 2,595 total
Award
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-03+24,160→ 24,160 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-02-03$48.44/sh+2,188→ 8,720 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-03−2,188→ 26,250 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-02-03$59.60/sh+1,657→ 8,189 total
Award
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-03+38,500→ 38,500 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-02-03$65.00/sh−1,657→ 6,532 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-03−1,657→ 13,250 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-02-03$62.81/sh−2,188→ 6,532 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-01−2,125→ 8,500 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-01−1,037→ 3,113 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-02-01+6,100→ 8,695 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2020-02-01−2,938→ 17,625 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2020-02-01$65.26/sh−2,163→ 6,532 total
Award
Global Blood Therapeutics, Inc.
Common Stock
2020-01-31$36.68/sh+579→ 2,595 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-27−781→ 4,688 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2020-01-27$27.90/sh+781→ 2,797 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2020-01-27$71.15/sh−781→ 2,016 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2019-12-13+4,000→ 4,000 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Restricted Stock Units
2019-12-13−4,000→ 0 total
Tax Payment
Global Blood Therapeutics, Inc.
Common Stock
2019-12-13$76.88/sh−1,984→ 2,016 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2019-12-09$19.89/sh+937→ 937 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2019-12-09−937→ 2,813 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2019-12-09$78.50/sh−937→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
2019-11-26−11,593→ 14,907 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2019-11-26$67.19/sh−11,593→ 0 total
Exercise/Conversion
Global Blood Therapeutics, Inc.
Common Stock
2019-11-26$59.60/sh+11,593→ 11,593 total

Companies

Recent Filings

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 171 OYSTER POINT BLVD., SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov